Stay updated on Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial
Sign up to get notified when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page.

Latest updates to the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedStudy status updated to Terminated; enrollment difficulties arose as patients opted for ovarian ablation to obtain insurance reimbursement, making them ineligible for participation.SummaryDifference0.4%

- Check42 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference4%

- Check49 days agoChange DetectedUpdate: version tag updated from v3.0.2 to v3.1.0. The page now indicates the newer release.SummaryDifference0.1%

- Check63 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2; the Back to Top element was removed. Core content, pricing, stock, and time-slot data remain unchanged.SummaryDifference0.2%

- Check70 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check78 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with a list of relevant publications from PubMed, while several specific terms and related topics have been removed.SummaryDifference10%

Stay in the know with updates to Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page.